Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Repurchase of Common Stock

Amag Pharmaceuticals Repurchase of Common Stock Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Repurchase of Common Stock from 2013 to 2020.
  • Amag Pharmaceuticals Repurchase of Common Stock for the quarter ending June 06, 2020 was $0m a 40.52% decrease of 0m year over year
  • Amag Pharmaceuticals Repurchase of Common Stock for the last 12 months ending June 06, 2020 was $-1m a -1,007.74% increase of 14m year over year
  • Amag Pharmaceuticals Annual Repurchase of Common Stock for 2019 was $-16m a 82.76% decrease of -13m from 2018
  • Amag Pharmaceuticals Annual Repurchase of Common Stock for 2018 was $-3m a -726.32% increase of 19m from 2017
  • Amag Pharmaceuticals Annual Repurchase of Common Stock for 2017 was $-22m a -0.04% increase of 0m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Repurchase of Common Stock Data

06/2020$0m
03/2020$-1m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$-15m
12/2018$0m
09/2018$0m
03/2018$-2m
12/2017$-20m

Annual AMAG Repurchase of Common Stock Data

2019$-16m
2018$-3m
2017$-22m
2016$-22m